Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Buyback Record Date | |
| Buyback Open Date | July 15, 2022 |
| Buyback Closing Date | January 14, 2023 |
| Issue Size (Amount) | ₹60.00 Crores |
| Buyback Price | ₹60 per Share |
October 15, 2020 2:27:00 AM
One of India's best-known investors, Ashish Kacholia, bought nearly 51 lakh shares of Marksans Pharma in the September quarter, data on BSE shows. In a regulatory filing on October 14, Marksans ...
Published by : moneycontrol.comNovember 22, 2024 4:05:00 PM
Marksans Pharma Ltd has gained final USFDA approval for its generic Loratadine tablets, used to treat allergic rhinitis. This approval allows the company to market a generic version of Clartin, ...
Published by : devdiscourseNovember 7, 2017 9:57:00 PM
Marksans Pharma has received approval from the US health regulator for loratadine liquid filled capsules, used for treatment of allergies, in the American market. The company has been granted the ...
Published by : health.economictimes.indiatimesRead Marksans Pharma Buyback current news. Find Marksans Pharma Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Marksans Pharma Ltd Buyback grey market premium and Marksans Pharma Buyback expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
